1 code page views remaining today. Guest accounts are limited to 2 daily page views. Register free account to get more views.
Log in Register free account
Code deleted. To report administration of COVID-19 vaccine, use 90480.

Official Description

Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; second dose

© Copyright 2025 American Medical Association. All rights reserved.

Short Descr ADM SARSCOV2 5MCG/0.5ML 2ND
Medium Descr IMM ADMN SARSCOV2 5 MCG/0.5 ML 2ND DOSE
Long Descr Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; second dose
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Not Discounted when Multiple
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
Date
Action
Notes
2025-01-01 Deleted First appearance of code deletion in codebook.
2023-11-01 Deleted Code deleted. To report administration of COVID-19 vaccine, use 90480.
2022-10-19 Note AMA guideline changed. 0044A received FDA approval
2022-10-10 Note AMA guideline changed to include 0044A effective upon receiving Emergency Use Authorization or approval from the FDA
2022-10-10 Note Changes made to include 12 years and older.
2022-08-31 Note Changes made to vaccine patient age (18+).
2022-07-13 Added Received FDA Approval
2022-07-13 Note AMA guideline changed. FDA approval received for 91304. Approval published to website 2022-07-26. FDA approval effective retroactively to 2022-07-13.
2022-07-13 Note AMA Guideline changed. 0041A received FDA approval.
2022-01-01 Added First appearance in codebook.
2022-01-01 Note Grammar correction
2022-01-01 Changed Code description changed.
2021-05-04 Added Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration.
2021-05-04 Note AMA guideline added to include 0041A, 91304; Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the FDA.
Code
Description
Code
Description